NCT05267691

Brief Summary

A hospital based cross-sectional study was conducted from 2017 to February 2021. Clinical history, examination and histopathological variants were collected from medical files and pathology reports. Confirmation of pathology was done in all the patients visiting skin and plastic surgery department with suspected lesions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
5.2 years until next milestone

First Submitted

Initial submission to the registry

February 24, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 4, 2022

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2022

Completed
Last Updated

July 20, 2022

Status Verified

July 1, 2022

Enrollment Period

5.2 years

First QC Date

February 24, 2022

Last Update Submit

July 18, 2022

Conditions

Dermatological Tumors

Outcome Measures

Primary Outcomes (1)

  • Healing

    Complete removal of the lesion

    1 day

Secondary Outcomes (1)

  • Recurrence

    1 year

Study Arms (2)

sun-protected

All patients with basal cell carcinoma in a sun protected body site

Procedure: Excision

sun-exposed

All patients with basal cell carcinoma in a sun exposed body site

Procedure: Excision

Interventions

ExcisionPROCEDURE

Surgical excision of the lesion and histopathology evaluation using Hematoxylin and Eosin stains

sun-exposedsun-protected

Eligibility Criteria

Age10 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Visiting dermatology or surgery clinics in the tertiary hospital

You may qualify if:

  • Excised lesion
  • Confirmed basal cell carcinoma pathologically

You may not qualify if:

  • Incision biopsy
  • Incomplete follow up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Abdulkarim Hasan

Cairo, 11884, Egypt

RECRUITING

MeSH Terms

Conditions

Skin Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Abdulkarim Hasan

    Al-Azhar University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Abdulkarim Hasan, MD

CONTACT

doctorabdulkarim7@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Laboratory coordinator

Study Record Dates

First Submitted

February 24, 2022

First Posted

March 4, 2022

Study Start

January 1, 2017

Primary Completion

March 20, 2022

Study Completion

October 20, 2022

Last Updated

July 20, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)